A new tally finds that nearly half of the U.S. adult population might be eligible to take semaglutide to battle obesity, ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...

A University of Florida study finds that people with diabetes who participate in telehealth doctor visits report the same ...

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

A mother is charged with second-degree murder after her 12-year-old daughter died from untreated diabetes. According to the ...

November is Diabetes Awareness Month and the Barker Lions Club is doing its part to increase community knowledge about the ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...